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Abstract
Gelsolin is a cytoskeletal protein which participates in actin filament dynamics and promotes cell motility and plasticity.
Although initially regarded as a tumor suppressor, gelsolin expression in certain tumors correlates with poor prognosis and
therapy-resistance. In vitro, gelsolin has anti-apoptotic and pro-migratory functions and is critical for invasion of some types
of tumor cells. We found that gelsolin was highly expressed at tumor borders infiltrating into adjacent liver tissues, as
examined by immunohistochemistry. Although gelsolin contributes to lamellipodia formation in migrating cells, the
mechanisms by which it induces tumor invasion are unclear. Gelsolin’s influence on the invasive activity of colorectal cancer
cells was investigated using overexpression and small interfering RNA knockdown. We show that gelsolin is required for
invasion of colorectal cancer cells through matrigel. Microarray analysis and quantitative PCR indicate that gelsolin
overexpression induces the upregulation of invasion-promoting genes in colorectal cancer cells, including the matrix-
degrading urokinase-type plasminogen activator (uPA). Conversely, gelsolin knockdown reduces uPA levels, as well as uPA
secretion. The enhanced invasiveness of gelsolin-overexpressing cells was attenuated by treatment with function-blocking
antibodies to either uPA or its receptor uPAR, indicating that uPA/uPAR activity is crucial for gelsolin-dependent invasion. In
summary, our data reveals novel functions of gelsolin in colorectal tumor cell invasion through its modulation of the uPA/
uPAR cascade, with potentially important roles in colorectal tumor dissemination to metastatic sites.
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Introduction
Colorectal cancer (CRC) accounts for one of the highest
mortality rates from cancer worldwide. The survival rate is highest
at about 90% when diagnosed at early stages where tumor growth
is localized to primary sites and about 35%–70% in invasive but
regional disease. However the occurrence of distant metastasis to
the liver or lungs in CRC is a major contributing factor to death,
with five-year survival rate at less than 15% [1]. The pathogenesis
of CRC from normal colonic epithelium to adenoma is fairly well-
characterized and often involves a number of genetic alterations,
including mutational activation of oncogenes such as K-ras as well
as mutational inactivation of tumor suppressors such as p53 [2]
and adenomatous polyposis coli (APC) gene [3]. In contrast, less is
known about the molecular mechanisms which convert a non-
invasive colorectal neoplasm to one with an invasive phenotype. In
most solid tumors, the spread of tumor cells is facilitated by events
which result in the detachment of malignant cells from the primary
site and subsequent dissemination through tissues and vasculature
[4]. This metastatic cascade is critically dependent on the
integration of migratory and invasive signals involving cytoskele-
ton and extracellular matrix (ECM) remodeling [5].
Gelsolin is an actin-binding protein which severs and caps actin
filaments [6], and regulates cytoskeletal turnover. Gelsolin appears
to have complex roles in tumor biology, with evidence supporting
its contradictory involvement in both tumor suppression as well as
malignant progression. Gelsolin is reported to be down-regulated
in tumors including breast [7] and lung [8] carcinomas, suggesting
that loss of gelsolin promotes oncogenesis. Consistent with this,
knockdown of gelsolin by small-interfering RNA (siRNA) in the
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immortalized human breast epithelial MCF10A cell line induced
changes suggestive of epithelial-mesenchymal transformation [9].
However, there is also evidence that the re-emergence of gelsolin
in tumors may promote aggressive behavior, as progressively
malignant stages in cancer are associated with high gelsolin
expression. Increased gelsolin expression was found to correlate
with lymphatic invasion in small cell lung cancer [10] and higher
tumor grade in renal cell carcinoma [11]. Intriguingly, in
urothelial and oral carcinomas, gelsolin exhibited a biphasic
expression profile, being down-regulated in premalignant lesions
but increased in higher grade lesions [12,13]. Furthermore, the co-
expression of gelsolin with erb-B2 and epidermal growth factor
receptor (EGFR) is a predictor of poor prognosis in breast cancer
[14]. It is likely that the role of gelsolin differs during the course of
tumor progression, and in more advanced disease gelsolin may
cooperate with other oncogenic factors to accelerate progression.
Several in vivo and in vitro studies clearly indicate that gelsolin is
crucial for migration and invasion in several cell types, including
migration of untransformed cells such as fibroblasts and neutrophils
[15,16], as well as invasion of transformed immortalized human and
canine kidney cells [17] and tumor cells includingbreast andprostate
cancer cells across collagen andmatrigelmatrices [18,19].Gelsolin’s
pro-migratory effects have been attributed to its actin-severing
actions [16,20]. However, its pro-invasive activities in epithelial
cancers are unclear, and may involve a combination of mechanisms
includingmigrationandinteractionswithsignalingproteins.Gelsolin
has been shown to be a downstream effector of signaling pathways
mediating invasion, including Ras and Rac GTPases, as well as
phosphotidylinositol 3-kinase (PI3K) [17,20].Gelsolin also facilitates
osteoclast podosome formation [21], and associates with the
oncogenic tyrosine kinase Src in these structures [22]. Podosomes
are rich inactinandmediatedynamiccell-matrixadhesionandECM
remodeling [23,24]. Although there is now a pool of convincing
evidence linking gelsolin to invasion [17,18,19], there is little insight
(beyond gelsolin’s role in actin dynamics) on the mechanisms
downstream of gelsolin leading to invasion. Previous studies have
correlated the expression of actin-associated proteins such as
cortactin and Lim Kinase-1 (LIMK1) with protease secretion
[25,26], and it is unknown whether gelsolin also modulates the
proteolyticmachinery to induce invasion. This study aims to address
the gap in knowledge between gelsolin and the matrix degradation
process during cancer cell invasion.
We investigated the influence of gelsolin on colorectal tumor cell
dissemination and the mechanisms underlying its pro-invasive
activity. Immunohistochemical (IHC) analysis showed prominent
gelsolin expression along the tumor borders of both primary human
colon tumors and liver metastases. The effects of gelsolin in human
colorectal tumor cells were examined by inducing gelsolin over-
expression as well as silencing with siRNA.Microarray analysis and
quantitative PCR in these models indicated that gelsolin modulates
the expression of several invasion-related genes in the urokinase-type
plasminogen activator (uPA) cascade, resulting in activation of
plasmin, a potent matrix degradation protease [27]. uPA and its
receptor uPAR were further determined to be crucial for gelsolin-
dependent invasion in colorectal tumor cells. Our work thus
elucidates a novel role for gelsolin in colorectal tumor dissemination,
by modulation of the uPA cascade which is crucial for invasion.
Results
Gelsolin Expression is Prominent at the Invasive Front of
Colorectal Tumors
We analyzed the expression of gelsolin by IHC in 24 primary
colorectal tumors and 26 colorectal liver metastases as well as 15
normal tissues from the surgical margins of clearance. Gelsolin
expression in tumor tissues as well as the adjacent normal tissues
was scored for intensity of staining (scale 0–3) and proportion of
tumor positivity (scale 0–3). Primary antibody exclusion as well as
mouse IgG were included as negative controls (Figure S1). In the
adjacent normal colonic mucosa, the expression was prominent at
the surface epithelium which comprises absorptive cells but weakly
expressed in goblet cells (Figure S2). In positively-stained mucosal
cells, gelsolin was present in the cytoplasm and nuclear staining
was generally observed in a small proportion of cells. Gelsolin was
highly expressed in myocytes of the muscularis propria and in
vessel walls, consistent with previous findings [28,29], as well as
lymphoid cells.
We found gelsolin expression to be heterogeneously expressed in
the matched primary tumors and liver metastases, with regions of
low and high expression seen within a tumor. Gelsolin was
detectable in the cytoplasm as well as the nuclei of tumor cells
(Figure 1). Emerging evidence supports the importance of
identifying changes within specific tumor populations, such as
those at the infiltrating borders which are involved in tumor
invasion and metastasis [30]. We therefore analyzed the pattern of
gelsolin expression at the tumor borders compared to the tumor
bulk, as these populations are potentially disseminative. In order to
define the infiltrative tumor borders, adjacent sections of liver
metastases were also stained with the pan-cytokeratin stain, AE1/
3, which identifies tumor cells of epithelial origins. Gelsolin
expression was pronounced along the tumor borders compared to
tumor bulk in both primary tumors and liver metastases (Figure 2).
In liver metastases, gelsolin expression was significantly higher in
the tumor borders compared to the main tumor bulk (p = 0.0075,
Mann-Whitney test). Interestingly we also observed high gelsolin
expression in infiltrating clusters of less-differentiated cells, some of
which appeared to be breaking away from well-formed glandular
structures, supporting the hypothesis that gelsolin is involved in
colorectal tumor cell invasion and dissemination. Our data
suggests that gelsolin is further upregulated along the metastatic
tumor borders and may promote secondary spread of colorectal
cancer cells within the primary and secondary host tissues.
Gelsolin expression was also determined in a panel of commer-
cially-available colorectal tumor cell lines derived from primary
tumors (HCT116, HT29, WiDr, RCM-1, RKO, Caco-2, SW837,
SW480, SW403, DLD-1, LS513) as well as those obtained from
metastatic lymph node (SW620) and ascites (COLO201 and
COLO205). Among the commercially-available cell lines, the
ascites-derived COLO201 and COLO205 and the primary tumor
cell lines DLD-1 and LS513 expressed the highest levels of gelsolin
(Figure S3).
Gelsolin Promotes Migration and Invasion of Colorectal
Tumor Cells
The oncogenic potential of gelsolin in colorectal tumor cells was
investigated by modulating gelsolin levels using gelsolin over-
expression and siRNA knockdown. Using the technique of in-vivo
passaging through athymic nude mice, we had previously
established the highly metastatic colon carcinoma E1 cell line
from the poorly-metastatic HCT116 cell line [31]. HCT116 was
observed to express intermediate levels of gelsolin in a panel of
colorectal carcinoma cell lines investigated (Figure S3). Consistent
with our hypothesis that there exists a correlation between
metastatic potential and gelsolin levels, E1, the metastatic variant,
expressed increased gelsolin levels compared to HCT116
(Figure 3A). To further investigate this, we overexpressed gelsolin
in HCT116 cells and performed functional assays. Overexpression
of gelsolin in the HCT116 was induced by stable transfection with
Gelsolin Induces Cancer Invasion via uPA Cascade
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Figure 1. Gelsolin immunohistochemistry in human colorectal carcinoma tissues. Gelsolin is heterogeneously expressed in a number of
primary tumors (A) and liver metastases (B), with islands of low (arrowed in blue) and high (arrowed in red) expression observed within a tumor.
Gelsolin expression is mainly cytoplasmic but occasionally, nuclear (C) and perinuclear (D) staining are detected (arrowed). Gelsolin is strongly
expressed in a mucinous adenocarcinoma (E) and in stroma (A, B).
doi:10.1371/journal.pone.0043594.g001
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the pIRES2-EGFP plasmid encoding human cytoplasmic gelsolin
cDNA (Figure 3B; refer to Figure S4 for the cloned sequence of
gelsolin cDNA). Control HCT116 cells were generated by
transfection with the empty pIRES2-EGFP plasmid. In addition
gelsolin expression was reduced using siRNA knockdown in
several colorectal tumor cell lines (HCT116 and its metastatic
variant E1, gelsolin-overexpressing HCT116, DLD-1 and Caco-
2), and compared to cells transfected with control siRNA. As
shown in Figure 3C, gelsolin was greatly reduced after gelsolin
siRNA treatment in these cell lines. The effects of gelsolin
overexpression and knockdown in colorectal tumor cells were
determined as described in the sections below.
Gelsolin overexpression in HCT116 augmented migration
through uncoated transwells and invasion through matrigel-coated
transwells (Figure 3D). The invasiveness of the stably-transfected
gelsolin-overexpressing HCT116 cells as well as wild-type
HCT116 cells was significantly decreased by siRNA knockdown
of gelsolin expression, indicating a reliance on gelsolin for invasion
(Figure 3E). The pro-invasive role of gelsolin was consistently
demonstrated in E1 and DLD-1 cells, where reduction of gelsolin
by siRNA significantly attenuated invasion. Our observations
indicate that gelsolin confers invasive capacity in colorectal cancer
cells, which are consistent with the reported effects of gelsolin in
other types of cells [17,32].
Gelsolin Modulates the Expression of Genes Important
for Tumor Dissemination
Although gelsolin appears to be necessary for invasive behavior,
little is known about the mechanisms by which it enhances invasion.
This may partly be attributable to its ability to enhance cellular
motility through its influence on cytoskeletal dynamics such as when
lamellipodiaare formed[33].However, invasion isacomplexprocess
dependent on multiple contributory factors besides motility [5]. To
further elucidate the downstream mechanisms by which gelsolin
induces invasion in colorectal tumor cells, microarray analysis was
performed to screen for potential genes that are differentially
expressed when gelsolin levels are increased. The gene expression
profiles of four stable gelsolin-overexpressing HCT116 clones were
compared with two vector control HCT116 clones. The gelsolin-
overexpressing clones expressed a consistent pattern of differential
gene expression, suggesting that gelsolin induced specific changes in
gene expression ofHCT116 cells (Figure S5A). In total, we identified
469geneswithanaveragealteration inexpression levelofat least two-
fold.Using theGeneOntology functional annotation underDAVID
BioinformationResources, genes were classified into their respective
biological processes, including cell differentiation, cell motility and
regulation of cell adhesion (Figure S5B). The representative table of
genes modulated by gelsolin is supplied in Table S1.
Figure 2. Gelsolin expression is prominent at the invasive front of human colorectal cancer tumors. Gelsolin expression is high along
the tumor periphery in primary tumors and liver metastases. The tumor periphery is outlined as red dotted line. A magnified view of a region of
primary tumor edge (boxed) is shown on the bottom panel. The invading liver metastases shown are confirmed by cytokeratin stain, AE1/3, on an
adjacent slide (bottom middle panel). Increased gelsolin expression was also detected in less-differentiated tumor cells which appeared to be
breaking away from well-formed glandular structures (arrowed, top right panel). Gelsolin expression were scored and represented in the scatter dot
plot (bottom). The median scores are represented by the red horizontal bars. Mann-whitney test was to compare the gelsolin expression score
between the main tumor bulk and their periphery. Bar: 50 mm.
doi:10.1371/journal.pone.0043594.g002
Gelsolin Induces Cancer Invasion via uPA Cascade
PLOS ONE | www.plosone.org 4 August 2012 | Volume 7 | Issue 8 | e43594
Figure 3. Gelsolin promotes migration and invasion of colorectal cancer cells. (A) Endogenous gelsolin level was increased in an in vivo-
derived metastatic variant of HCT116, E1, which was described in [31]. (B) Gelsolin overexpression plasmid was constructed by cloning human
cytoplasmic gelsolin cDNA into pIRES2-EGFP vector (left). HCT116 cells were either transfected with gelsolin-pIRES2-EGFP plasmid or empty pIRES2-
EGFP plasmid to establish stable gelsolin-overexpressing cell lines and vector control cell lines respectively. Western blot analysis confirmed increased
gelsolin expression in HCT116 cell lines stably-transfected with the gelsolin-overexpression plasmid compared to those transfected with control
plasmid. (C) Western blot showing transient gelsolin siRNA knockdown (KD) at 3 days in wild-type HCT116 and gelsolin-overexpressing HCT116 cells,
E1, as well as other colorectal cancer cell lines DLD-1 and Caco-2 cells. Control cells (Cont) were treated with control siRNA. (D) Increased gelsolin in
HCT116 enhanced tumor cell migration and invasion. The migration of gelsolin-overexpressing HCT116 cells through uncoated transwells and
Gelsolin Induces Cancer Invasion via uPA Cascade
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Gelsolin Modulates the Expression of Invasion-associated
Urokinase-type Plasminogen Activator (uPA)
Among the invasion-associated genes identified to be induced
by more than 2-fold in gelsolin-overexpressing cells is the serine
protease, urokinase-type plasminogen activator (uPA), which is
involved in the plasminogen activation cascade that results in the
activation of a broad-spectrum protease plasmin. Although
microarray analysis detected less than 2-fold changes in the levels
of other uPA cascade genes, we included these in real-time PCR
analysis as these comprise important components for regulating
uPA-dependent matrix degradation. Besides uPA, the following
genes were screened for mRNA expression: the uPA receptor
uPAR, and known inhibitors of the uPA cascade including
plasminogen activator inhibitor-1 (PAI-1), plasminogen activator
inhibitor-2 (PAI-2) and a2-antiplasmin (a2-AP) [34]. Real-time
PCR showed that increased levels of gelsolin in HCT116 cells
upregulated the expression of uPA and uPAR, and reduced the
levels of the inhibitors PAI-2 and a2-AP (Figure 4A). Consistent
with observations in the overexpression studies, mRNA levels of
uPA were also reduced by siRNA knockdown of gelsolin in wild-
type HCT116, DLD-1 and Caco-2 cells (Figure 4B). The mRNA
levels of uPAR were reduced by gelsolin siRNA-treated HCT116
and Caco-2 cells but not in DLD-1 cells. Our data indicates that
uPA levels are altered by changes in gelsolin expression, and the
uPA cascade is a possible mechanism through which gelsolin
mediates invasion.
Gelsolin Increases uPA Secretion by Colorectal Tumor
Cells and Promotes Invasion through the uPA Cascade
In the plasminogen activator cascade, the secretion of uPA is
required to activate the proenzyme plasminogen to active plasmin
in the extracellular environment. We investigated the levels of
secreted uPA protein in the conditioned media of gelsolin-
overexpressing colorectal cancer cells obtained after 48 hours of
serum-deprivation, using enzyme-linked immunosorbent assays
(ELISA). Consistent with the increase in uPA gene expression, we
also detected significantly increased uPA secretion in gelsolin-
overexpressing HCT116 compared to control cells (Figure 5A).
We examined the effects of gelsolin-induced uPA expression on
matrix degradation using zymographic analysis. Conditioned
media of the cells were loaded and electrophoresed in zymo-
graphic gels containing plasminogen and fibrinogen for analysis of
uPA activity. Gelsolin-overexpressing HCT116 cells displayed
greater uPA activity in comparison to vector control and wildtype
HCT116, as evident from the enhanced lysis zones (Figure 5A).
The increased proteolytic ability of gelsolin-overexpressing cells, as
ascertained by our zymographic analysis, corroborates with earlier
observations from the transwell invasion assay which showed that
gelsolin conferred invasiveness in colorectal cancer cells
(Figure 3D–E). Conversely, siRNA knockdown of gelsolin in the
colorectal tumor cell lines HCT116, DLD-1 and Caco-2
significantly reduced the level of secreted uPA and its proteolytic
activity (Figure 5B). Our data suggests that gelsolin modulates uPA
activity on the extracellular matrix by influencing uPA expression
and its secretion.
The cytokine, tumor necrosis factor alpha (TNF-a), is produced
by several types of tumors and has been reported to stimulate uPA
production [35] and enhance invasion [36]. As shown in
Figure 5C, treatment with TNF-a for 24 hours enhanced uPA
secretion in DLD-1 and Caco-2 cells. However when gelsolin
expression was reduced by siRNA knockdown, the increases in
uPA secretion induced by TNF-a were significantly attenuated to
levels similar to that in control cells. Our data shows that TNF-
a induced uPA secretion is attenuated in the absence of gelsolin.
However, it is currently unclear how gelsolin modulates uPA
secretion in response to TNF-a stimulation.
The involvement of the uPA cascade in the increased
invasiveness of gelsolin-overexpressors was further confirmed by
inhibiting uPA function and examining the effects on invasion
through matrigel. The highly invasive gelsolin-overexpressing
HCT116 cells were treated with function-blocking antibodies
against either uPA or uPAR, or by treatment with the uPA
inhibitor amiloride [37]. Control experiments were conducted
using isotype-control mouse IgG and vehicle control dimethyl
sulfoxide (DMSO), respectively. Blockade of the uPA cascade
using either anti-uPA or anti-uPAR antibody, or amiloride
significantly attenuated the invasiveness of gelsolin-overexpressing
HCT116 cells across matrigel, by 40% to 55% (Figure 5D). Our
data indicated that gelsolin enhances invasion through the uPA
activator cascade, by promoting uPA secretion which can enhance
matrix degradation.
Apart from members of the uPA cascade, the genes of various
other proteases or related proteins such as metalloproteinase-7
(MMP7) and TIMP2 were also modulated by gelsolin over-
expression in HCT116 (Table S1). Since tumor cells may secrete
different proteases during the course of dissemination, we in-
vestigated whether the gelsolin-mediated invasion may involve,
besides uPA, members of the MMP family. Gelsolin-overexpres-
sing cells were subjected to similar transwell invasion assays
following treatment with either the synthetic pan-MMP inhibitor
GM6001 (which blocks MMP-1, -2, -3, -8 and -9 activities) or
other specific inhibitors to MMP-2, MMP-2/29, MMP-3, MMP-
7 and MMP-8. Pan-MMP inhibition using GM6001, as well as
MMP-2 inhibition reduced the invasiveness of cells by about 20%,
although the results were not statistically significant (Figure S6).
The simultaneous inhibition of MMP-2/MMP-9 showed similar
effect to inhibition of MMP-2 alone, suggesting that MMP-9
played little or no role in the invasion of gelsolin-overexpressing
cells. There was however no significant increase in the MMP-2
activity in gelsolin-overexpressing cells compared to vector control
and HCT116 based on gelatin zymography (Data not shown).
Inhibition of MMP-3, MMP-7 and MMP-8 had no effect on
invasion (Figure S6). Taken together our data indicated that in
addition to its pro-migratory role, gelsolin promotes invasion in
the colorectal carcinoma cells predominantly via increased
expression and secretion of uPA.
Discussion
In this study, we show that invading populations of tumor cells
enriched in gelsolin are found in both primary as well as metastatic
human colorectal cancers. This is consistent with earlier observa-
tions of prominent gelsolin expression along the invasive front of
liver metastases, in contrast to its low expression in primary
colorectal adenocarcinomas [28]. The significance of ‘‘leading
cells’’ at the invasive front of tumors in promoting tumor spread
invasion through matrigel-coated transwells were ascertained over 48 hours, and was observed to be increased compared to vector control cells. (E)
siRNA downregulation of gelsolin abrogates invasion. Gelsolin knockdown significantly reduced invasion of HCT116 and gelsolin-overexpressing
HCT116 through matrigel. A requirement for gelsolin in invasion was also observed in E1 and DLD-1 cells. All data shown are the mean 6 standard
error of duplicate measurements and are representative of at least three independent experiments. *P,0.05.
doi:10.1371/journal.pone.0043594.g003
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has been highlighted in a number of studies. Cells at the invasive
edge acquire molecular changes such as increased expression of
matrix-digesting proteases and integrins for matrix-remodelling
[38,39], which may be accompanied by a switch towards
a mesenchymal-like, dedifferentiated phenotype. These changes
in leading cells at the invasive front drive proteases- and force-
mediated matrix remodeling which pave the way for collective cell
invasion by non-invasive ‘‘follower cells’’ [39]. Notably, the
increased tumor aggressiveness has been associated with increased
expression or altered localization of other actin-binding proteins
such as b-catenin [30], actinin-4 [40], cortactin [41] and fascin
[42] at the invasive region of tumors. We have demonstrated here
that gelsolin is crucial for the invasive behavior of colorectal tumor
cells. Gelsolin has previously been shown to be important for
migration of fibroblasts and invasion of other tumor cells,
attributable partly to its actin-depolymerizing effects. However,
invasion involves the coordination of multiple mechanisms, which
include migration and ECM degradation. It is conceivable that the
Figure 4. Gelsolin modulates the expression of invasion-associated urokinase-type plasminogen activator (uPA) cascade in
colorectal cancer cells. (A) uPA was detected by microarray analysis to be differentially regulated by gelsolin overexpression. The average gene
expression fold changes in the gelsolin-overexpressing clones compared to vector control clones are shown. The gene expression was verified by
real-time PCR, and indicated that increased gelsolin upregulated uPA and uPAR mRNA, and decreased mRNA expression of endogenous inhibitors of
uPA and plasmin, PAI-2 and a2-AP, respectively. The relative mRNA levels were normalized to vector control cells. (B) siRNA knockdown of gelsolin
reduced uPA levels in colorectal cancer cells. Real-time PCR showing the relative mRNA expression of uPA and uPAR in HCT116, DLD-1 and Caco-2
cells after treatment with gelsolin siRNA as compared to control siRNA. All data shown are the mean6 standard error of triplicate measurements and
are representative of at least three independent experiments. *P,0.05.
doi:10.1371/journal.pone.0043594.g004
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Figure 5. Gelsolin increases uPA secretion of colorectal tumor cells and enhances invasion via the urokinase-type plasminogen
(uPA) cascade. (A) Increased gelsolin in HCT116 cells augmented the secretion and activity of uPA. The levels of secreted uPA by cells cultured for
48 hours in serum-free conditions were detected in the supernatant using ELISA. Gelsolin-overexpressing HCT116 cells secreted significantly higher
uPA levels compared to control cells (left), which correlated with higher uPA enzymatic activity, as evident from uPA zymographic analysis using 16-
Gelsolin Induces Cancer Invasion via uPA Cascade
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effect of gelsolin siRNA knockdown on invasion through matrigel
may be partially attributed to a reduced migratory capacity of
cells. However, the pro-invasive role of gelsolin via matrix
degradation was reaffirmed by zymographic analyses, which
enabled the detection of proteolytic activity of secreted proteases.
Our work shows that, in addition to previous work highlighting
gelsolin’s roles in driving lamellipodia protrusion and turnover in
migration [43], gelsolin also confers invasive properties via its
ability to modulate the expression of well-known mediators of
tumor invasion - genes involved in the uPA cascade which degrade
the ECM.
The uPA cascade is initiated when secreted uPA from cancer
cells [44] or stromal components [45] binds to its receptor uPAR
and converts the inactive plasminogen to active plasmin by
proteolytic cleavage. Plasmin promotes remodeling of ECM by
direct proteolysis, or indirectly through activation of MMPs
[46,47]. The uPA system is implicated as a major factor leading to
aggressive tumor behaviour, as it promotes invasion and metastasis
in several tumor types including colorectal cancer [48,49]. uPA
and uPAR activities contribute to proteolysis of ECM at the
invasive front of tumors [50], and elevated levels in colorectal
tumors correlate with tumor progression and poor survival
[51,52].
Our findings revealed the ability of gelsolin to modulate uPA
gene expression and secretion. The roles of cytoskeletal proteins in
regulation of gene expression is an emerging field of interest, as it is
now clear that the nuclear cytoskeleton participates in several
transcriptional regulatory processes [53]. Indeed, actin-binding
proteins, including gelsolin and its family members have
prominent roles in mediating nuclear receptor-directed transcrip-
tion [54]. Gelsolin was previously reported to physically interact
with androgen receptor (AR) and enhance AR transcriptional
activity, [55]. More recently, gelsolin was found to be a key
determinant for the assembly and/or stability of estrogen receptor
nucleus complexes [56]. Interestingly, the nuclear import of
CapG, another gelsolin family member, is suggested to interfere
with chromosome condensation [53] and promote invasion into
collagen [57]. It is unknown if gelsolin also regulates non-nuclear
receptor-dependent transcription, though its presence in the nuclei
of colorectal tumor tissues suggests wider roles for nuclear-
associated gelsolin. As yet, it is unclear how gelsolin regulates uPA
gene expression - this would be an interesting avenue for further
exploration into gelsolin’s roles in transcriptional regulation of
invasion genes.
Besides modulating the mRNA levels of uPA, we also found that
gelsolin regulates uPA secretion by colorectal cancer cells.
Increased circulating levels of plasma uPA have previously been
associated with advanced cancers including colorectal [58] and
prostate cancers [59]. Very recently gelsolin was reported to
regulate insulin exocytosis through its direct interaction with
syntaxin 4, a plasma membrane protein which mediates docking of
transport vesicles [60]. The expression of other actin-associated
proteins, such as cortactin and LIMK1, has also been reported to
correlate with the secretion of matrix proteases including MMPs
[25,26,61]. LIMK1 in particular, which regulates the activities of
actin-depolymerizing factor (ADF/cofilin), has also been shown to
interact with membrane type 1 (MT1)-MMP and regulate its
vesicular trafficking [25]. It is possible that gelsolin may also
participate in the transport of vesicles containing uPA or other
proteases through its influence on F-actin dynamics which is
essential for vesicular trafficking. Future studies on the role of
gelsolin in the secretory pathway of proteases such as uPA would
yield a clearer picture of the integration of the distinct but
synergistic cellular processes mediated by gelsolin to promote
invasion. Nevertheless, the revelation of gelsolin’s function in
regulating uPA expression and secretion in colorectal cancer
invasion provides further insight into the mechanisms behind
gelsolin’s oncogenic role, and lends support to the multiple roles of
actin cytoskeletal proteins in promoting cancer cell dissemination.
In the current study we also investigated the contribution of
a number of MMPs in the gelsolin-mediated invasion in colorectal
cancer cells. Inhibition of the gelatinase MMP-2 alone led to
a slight decrease in invasion but not the inhibition of MMP-3, -7, -
8 and -9 in gelsolin-overexpressing cells. Treatment with GM6001
which inhibits MMP-1 in addition to MMP-2, MMP-3, MMP-8
and MMP-9 reduced invasion to a small extent but the results
were not statistically significant. Interestingly proMMP-2 was
reported to be activated by plasmin [47,62], which may increase
the pool of active MMP-2. Although plasmin can also activate the
other gelatinase proMMP-9, it is pertinent to add that plasmin is
not an efficient activator of proMMP-9 [46]. Nevertheless, the
balance between MMPs and their endogenous inhibitors, tissue
inhibitor of metalloproteinases (TIMPs), is critical in determining
the net effect on matrix degradation. Our unpublished data
indicated that TIMP-2 was increased in gelsolin-overexpressing
HCT116 cells, with the direct implication being that the matrix-
degrading effects of MMPs can be counter-balanced. Of note,
literature also reveals paradoxical, pro-tumor roles of TIMPs in
cancer biology [63]. Due to the complexity of the biological
activities of MMPs and TIMPs, it is not within the scope of this
study to look into the interactions between MMPs and TIMPs in
detail. Moreover the evidence we presented in this manuscript
suggests that the uPA cascade is a major downstream pathway by
which gelsolin induce matrix degradation.
Together with the well-established functions of gelsolin in
cytoskeletal dynamics, our findings implicate gelsolin as a regula-
tory determinant of the uPA cascade, with significant impact on
colorectal cancer invasion. The potential contributions of gelsolin
hour serum-free conditioned media of cells (right). (B) Knockdown of gelsolin (KD) reduced the secretion of uPA. Gelsolin-overexpressing HCT116,
wildtype HCT116, DLD-1 and Caco-2 cells were treated with gelsolin siRNA or control siRNA for 24 hours prior to culture under serum-free conditions
for a further 48 hours. The levels of secreted uPA were detected using ELISA (left). Zymographic analysis indicated that uPA activity in the 3-hour
conditioned media of the colorectal tumor cells was reduced 48 hours after gelsolin siRNA knockdown treatment (right). (C) Gelsolin expression
affects TNF-a-stimulated uPA secretion in colorectal cancer cells. DLD-1 and Caco-2 cells were treated with gelsolin siRNA (KD) or control siRNA (Cont)
for at least 24 hours and serum-starved overnight prior to incubation with 5 ng/mL (DLD-1) and 10 ng/mL (Caco-2) TNF-a for 24 hours. The levels of
secreted uPA in the supernatant of cultured cells were detected using ELISA. uPA secretion was effectively stimulated by TNF-a in DLD-1 and Caco-2.
However, siRNA knockdown of gelsolin significantly attentuated TNFa-stimulated uPA levels in the colorectal cancer cell lines. (D) Inhibition of uPA
cascade attenuates the invasion of gelsolin-overexpressing HCT116 cells through matrigel. Gelsolin-overexpressing cells were treated with either
50 mM amiloride, 200 mg/mL of function-blocking anti-uPA or 80 mg/mL of anti-uPAR antibodies and examined for changes in invasive potential
through matrigel. DMSO treatment and mouse IgG antibody at 200 mg/mL were used as controls to amiloride and the function-blocking antibodies
and respectively. Untreated vector control HCT116 was included and normalized to DMSO vehicle control. The anti-uPA and anti-uPAR as well as
amiloride treatments significantly attenuated invasion of gelsolin-overexpressing HCT116 cells, indicating that the enhanced invasiveness induced by
gelsolin is mediated through the uPA cascade. All data shown are the mean 6 standard error of triplicate (ELISA) and duplicate (invasion assay)
measurements and are representative of at least two independent experiments. P,0.05 (student’s t test).
doi:10.1371/journal.pone.0043594.g005
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towards the further spread of tumor cells from liver metastases
warrant further investigations into the roles of cytoskeletal proteins
in metastatic disease. Further dissection of the mechanisms by
which gelsolin and other cytoskeletal proteins regulate invasive
pathways could contribute towards the understanding of how
cancer progresses, and the development of effective strategies
which counteract its spread.
Materials and Methods
Cell Lines and Reagents
HCT116, HT29, WiDr, RCM-1, RKO, Caco-2, SW837,
SW480, SW403, SW620, DLD-1, LS513, COLO201 and
COLO205 are human colon cancer cell lines obtained from
ATCC. The in vivo-derived metastatic E1 cell line was developed
from HCT116, as previously described [31]. HCT116, E1, HT29
and WiDr were cultured in McCoy’s 5A modified medium; Caco-
2, SW480, SW837, SW403 in Dulbecco’s Modified Eagle’s
Medium and DLD-1, RKO, LS513, RCM-1, COLO201,
COLO205 in RPMI 1640 (All media from Sigma-Aldrich). All
media were supplemented with 10% fetal bovine serum (FBS)
(Hyclone). Stable HCT116 cell lines overexpressing gelsolin and
empty vector control cell lines were grown using the McCoy’s 5A
medium with addition of 500 mg/ml Geneticin (Gibco). Cells were
maintained at 37uC in a humidified incubated with 5% CO2.
Antibodies used include mouse antibodies against human gelsolin
(Abcam), b-actin (Sigma-Aldrich), GAPDH (Santa Cruz Bio-
technology), pan-cytokeratin (AE1/3) (Dako), uPA (America
Diagnostica), uPAR, mouse IgG1 and goat IgG (R&D Systems).
Secondary antibody goat anti-mouse IgG conjugated with HRP
(Santa Cruz Biotechnology) was used. Metalloproteinase (MMP)
inhibitors include GM6001, MMP-2 Inhibitor I, MMP-2/MMP-9
Inhibitor IV, MMP-3 Inhibitor II, MMP-8 Inhibitor I (Calbio-
chem) as well as anti-MMP7 antibody (R&D Systems).
Construction and Transfection of Gelsolin-overexpression
Plasmids
A coding sequence of human gelsolin was amplified from
a PMW172 expression plasmid containing human cytoplasmic
gelsolin cDNA, by polymerase chain reaction (PCR) using the
forward primer 59CG GAA TTC ATG GTG GTG GAA CAC
CCC GAG TTC 39 and reverse primer 59 CG CCG CGG TCA
GGC AGC CAG CTC AGC CAT GGC 39, followed by cloning
of gelsolin insert into pIRES2-EGFP vector (Becton Dickinson) at
Eco RI and Sac II enzyme restriction sites. The resulting vectors
were transformed into competent Escherichia coli XL1B MRF’ cells
(Stratagene) and clones were selected based on kanamycin
resistance. Sequencing of the cloned gelsolin cDNA verified that
the cDNA sequence encodes the human cytoplasmic gelsolin
protein (Swiss-Prot accession P06396). To generate stable cell
lines, gelsolin- pIRES2-EGFP vector or empty vector were
transfected into HCT116 using FuGENE 6 (Promega) and
selected using 500 mg/ml G418.
Immunohistochemistry
24 primary colorectal tumors and 26 colorectal liver metastases
tissues as well as 15 adjacent normal colonic tissues were obtained
for use from the Department of Pathology, National University
Hospital, Singapore, with approval from the National University
of Singapore Institutional Review Board. Briefly, the 4 mm-thick
tissue specimens were deparaffinized, boiled in citric acid, and
treated with hydrogen peroxide, before incubation with anti-
gelsolin primary antibody overnight at 4uC, followed by in-
cubation with polymer-horse radish peroxidase-conjugated sec-
ondary antibody at room temperature. Sections were developed
with diaminobenzidine (DAB) and counterstained with hematox-
ylin. Images were acquired using Olympus BX43F microscope
equipped with a DP70 camera. Gelsolin staining in the muscularis
propria and stroma [28,29] were used as internal positive controls.
The intensity of staining was graded from 0 (undetectable) to 3
(intense staining), whilst the proportion of positive staining tumor
cells within a tissue was scored from 0 to 3 where: 1 =,30%,
2= 30–60%, 3=.60% of tumor cells identified. The staining
score was expressed as the product of intensity of staining and
proportion of tumor positivity. Both cytoplasmic and nuclear
staining were scored and summed. The maximum possible score
for a sample is therefore 18, the sum of the maximum cytoplasmic
(9) and nuclear scores (9).
siRNA Transfection
10 nM of the Stealth siRNA of the sequence 59 AAA CGU
CCA AUC UUG UUG GAG CAG G 39 (Invitrogen), complexed
with lipofectamine, was used to silence gelsolin expression in cells.
Medium GC control siRNA which matched the GC content of the
gelsolin siRNA used and no-siRNA treatment were included as
controls. Cells were harvested at 48 or 72 hours, and treated as
used in other assays as described.
Matrigel Invasion Assay
The transwell assay was carried out as previously described
[31]. 56104 cells were seeded for HCT116 and E1 cell lines and
36104 cells for DLD-1, for 48 hours. 10% FBS was used as
chemoattractant in the bottom transwell chamber. For function-
blocking experiments, cells were seeded with 200 mg/mL anti-uPA
or 80 mg/mL anti-uPAR (American Diagnostica). For MMP
inhibition treatments, 0.156106 gelsolin-overexpressing HCT116
cells were seeded for 24 hours with 40 mM of MMP inhibitor
(either GM6001 or MMP-2, MMP-2/-9, MMP-3 inhibitor),
except for MMP-8 inhibitor which was used at 1 mM. Mouse
IgG1and goat IgG were included as controls for anti-uPA/anti-
uPAR and anti-MMP7 respectively whereas the vehicle control
dimethyl sulfoxide (DMSO) was used alongside with the remaining
MMP inhibitor treatments. The same protocol was used for
migration studies but without the addition of matrigel coating on
the transwell membrane.
ELISA
For measurement of secreted uPA under standard culture
condition, cells were incubated in serum-free medium for 48 hours
before harvest of culture supernatant for assay. For stimulated
conditions, cells were serum-starved overnight prior to incubation
with either 5 or 10 ng/mL of human recombinant TNF-
a (PeproTech) in fresh serum-free media for 24 hours. As a control
for TNF-a stimulation, cells were incubated with serum-free media
in parallel. All harvested cell culture supernatants were kept at
220uC until analysis by ELISA. For measurement of secreted uPA
under gelsolin-knockdown conditions, cells were treated with
siRNA before the serum-starvation step on the following day.
Levels of uPA present in the neat supernatants were determined by
the human Duoset ELISA Development Kit (R&D Systems),
according to the manufacturer’s protocol.
Microarray Analysis
Microarray analysis was performed on the wild-type HCT116
cell line as well as stably-transfected HCT116 cells including four
gelsolin-overexpressing cell lines and two empty vector-transfected
control cell lines using Sentrix HumanRef-8 Beadchips (Illumina),
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according to the protocol outlined in the Illumina technical
manual. The arrays were scanned using Ilumina BeadArray
Reader and analyzed using BeadStudio version 3.1.3.0. For each
cell line, duplicates from two independent harvests were profiled.
The absolute data was exported into GeneSpring GX v7.3
software (Silicon genetics) for further analysis. The measurements
on each chip were first divided by the 50th percentile value, after
which the value obtained for each gene was normalized to the
average baseline median value of the control samples. One-way
ANOVA approach was used to identify differentially-expressed
genes and genes showing an average of at least a two-fold change
in expression level in the four gelsolin-overexpressing samples. The
output was then functionally annotated via Gene Ontology
functional annotation under DAVID Bioinformation Resources
(http://david.abcc.ncifcrf.gov/). The microarray data reported
here are described in accordance with MIAME guidelines, and is
accessible at Gene Expression Omnibus (GEO) database [64]
through GEO Series accession number GSE36588 (http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc =GSE36588).
Real Time Quantitative RT-PCR
Real Time PCR was used to validate gene expression change
from microarray data. 0.5–1.4 mg of cDNA was used for reverse-
transcription, carried out on the ABI 7300 Real time PCR system.
The thermal cycling conditions were as follows: one cycle at 95uC
for 10 minutes, followed by 40 cycles of denaturation at 95uC for
15 seconds and annealing extension at 60uC for 1 minute. The
primers used included uPA (Hs01547054_m1), uPAR
(Hs00182181_m1), PAI-1 (Hs00167155_m1), PAI-2
(Hs00234032_m1) and a2-antiplasmin (Hs00171467_m1).
GAPDH (Hs99999905_m1) was included as the internal control.
All reagents are from Applied Biosystems.
Western Blotting
Total cell lysates were extracted using lysis buffer (6 M urea, 1%
SDS, 2 M b-mercaptoethanol, 1 M Tris pH 7.4, PBS). Equivalent
amounts of protein from each sample were separated on 10%
SDS-PAGE gels and transferred to PVDF membranes, blocked
and incubated with primary antibody overnight at 4uC followed
by secondary antibody before chemiluminescence substrate de-
tection.
Zymography
Secreted uPA enzymatic activities were examined by zymo-
graphy. Briefly, cells were grown in serum-free medium for 3 to
16 hours. The conditioned media were normalized using cellular
lysate and then combined with non-reducing sample loading
buffer and loaded into 10% SDS-PAGE gels containing 730 ug/
mL of human fibrinogen and 20 ug/mL human plasminogen
(Sigma-aldrich). After electrophoresis, gels were rinsed with
distilled water and incubated with wash buffer (2.5% Triton X-
100 and 50 mM Tris-HCl pH 8.0) for 1 hour, followed by
incubation at 37uC with incubation buffer (0.1 M glycine buffer,
pH 8.0) for 16 hours. The gels were then stained with Coomassie
blue (0.05% Coomassie dye, 40% methanol, and 10% acetic acid)
for 1 hour at room temperature, and destained with distilled
water. Areas of lysis were expected to appear as zones of clearance
against the Coomassie blue-stained background of undegraded
substrate.
Statistical Analysis
Statistical analysis was performed using Student’s t-test except
for IHC gelsolin expression analysis in which Mann-Whitney test
was used. Differences between sample means were considered
statistically significant with P,0.05.
Supporting Information
Figure S1 Gelsolin immunohistochemistry in human
colon tissues. An example of gelsolin staining in adjacent liver
metastases section is shown here. Negative controls, including
primary antibody exclusion and IgG isotype control were included
to confirm the specificity of the gelsolin antibody used. Gelsolin
was consistently highly expressed in the stroma but stromal
stainings were mainly undetectable in the negative control
samples. Bar: 50 mm.
(TIF)
Figure S2 Gelsolin immunohistochemistry in normal
human colon tissues. Gelsolin is prominent in surface
epithelium cells (A, arrowed) and weakly expressed, or absent in
goblet cells (B, C). Cytoplasmic labelling is predominant, with
occasional nuclear localization (C, arrowed). Gelsolin is intensely
expressed in muscularis propria (D), vessel walls (E) and lymphoid
cells (F). Bar: 50 mm.
(TIF)
Figure S3 Gelsolin immunohistochemistry in human
colorectal carcinoma cell lines. In a panel of colorectal cell
lines, gelsolin levels are highest in COLO201 and COLO205,
both of which were obtained from metastatic ascites. Gelsolin
expression in the remaining primary tumor-derived cell lines
(except SW620 which was derived from lymph node) were more
varied. The graph displays normalized gelsolin expression to
HCT116. b-actin was used as loading control.
(TIF)
Figure S4 Cloned sequence of human cytoplasmic
gelsolin cDNA. Nucleotides 159 to 2354 was cloned. This
sequence is a 100% match with Genbank accession
#BC026033.1.
(TIF)
Figure S5 Gelsolin modulates the expression of genes
important for tumor dissemination. (A) The global gene
expression profile of four stable gelsolin-overexpressing HCT116
cell lines were compared against the pooled average of two vector
control cell lines using microarray analysis. Each horizontal row in
the cluster diagram represents a gene. Blue shades represent
downregulation while red shades represent upregulation in gene
expression relative to the vector control cells. All samples were
assayed in independent duplicates. (B) Biological function
classification of differentially-expressed genes from the microarray
output, using Gene Ontology annotation from DAVID bioinfor-
mation resources. Genes showing an average of at least two-fold
change in expression level in the four gelsolin-overexpressing
clones are represented in the classification. Gelsolin modulates the
genes involved in tumor dissemination including cell differentia-
tion, cell motility and the regulation of cell adhesion.
(TIF)
Figure S6 Gelsolin-overexpressing HCT116 may en-
hance invasion by MMP-2. Gelsolin-overexpressing cells were
treated with MMP inhibitors and examined for changes in invasive
potential through matrigel. The pan-MMP inhibitor GM6001 as
well as inhibitors to MMP-2, MMP-2/-9 and MMP-3 were used at
40 mM, MMP-8 inhibitor at 1 mM, and a-MMP7 antibody at
80 mg/mL. DMSO and goat IgG antibody were used as controls
to MMP chemical inhibitors and a-MMP7 antibody treatments
respectively. No significant reduction in invasion was observed in
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any of the MMP inhibitor treatments, although GM6001 and
MMP-2, MMP-2/29 inhibitors showed a slight reduction. All
data shown are the mean 6 standard error of at least duplicate
measurements and are representative of at least two independent
experiments.
(TIF)
Table S1 Gelsolin modulates the expression of genes
important for various cellular processes. Genes from the
microarray output were classified under various biological pro-
cesses using Gene Ontology annotation from DAVID bioinforma-
tion resources. Average fold change in gene expression is
determined from comparison between 4 gelsolin-overexpressing
HCT116 clones and 2 vector-control HCT116 clones.
(PDF)
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